Standard form for notification of major holdings | 27-Jun-2023 | 12:24 | RNS |
Pharma services contract with Artios Pharma | 25-May-2023 | 07:00 | RNS |
Board change - appointment of new Chairman | 22-May-2023 | 07:00 | RNS |
Results for the year ended 31 December 2022 | 21-Apr-2023 | 07:00 | RNS |
ANGLE announces partnership with BioView | 19-Apr-2023 | 07:00 | RNS |
Pharma Services Contract with Crescendo Biologics | 13-Apr-2023 | 07:00 | RNS |
Notice of Preliminary Results and Webcast | 03-Apr-2023 | 07:00 | RNS |
Issue of LTIP Options and Share Options | 10-Mar-2023 | 07:00 | RNS |
Holding(s) in Company | 09-Mar-2023 | 15:03 | RNS |
Director/PDMR shareholding | 09-Feb-2023 | 14:44 | RNS |
Appointment of Non-Executive Director | 19-Jan-2023 | 07:00 | RNS |
Holding(s) in Company | 11-Jan-2023 | 17:20 | RNS |
Holding(s) in Company | 10-Jan-2023 | 18:20 | RNS |
Second Price Monitoring Extn | 06-Jan-2023 | 11:05 | RNS |
Price Monitoring Extension | 06-Jan-2023 | 11:00 | RNS |
Currency | UK Pounds |
Share Price | 13.63p |
Change Today | -0.38p |
% Change | -2.68 % |
52 Week High | 31.35p |
52 Week Low | 9.24p |
Volume | 740,937 |
Shares Issued | 319.08m |
Market Cap | £43.47m |
RiskGrade | 312 |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
Strong Buy | 1 |
Buy | 0 |
Neutral | 0 |
Sell | 0 |
Strong Sell | 0 |
Total | 1 |
No dividends found |
Time | Volume / Share Price |
12:41 | 50 @ 14.00p |
12:39 | 19,834 @ 13.89p |
12:15 | 13,500 @ 13.78p |
11:37 | 357 @ 14.00p |
11:36 | 10,000 @ 13.78p |
CEO | Andrew D Newland |
Finance Director | Ian F Griffiths |
Chair | Jan Groen |
You are here: research